• Anlotinib Hydrochloride Blocks Angiogenesis via Multi-Kinase

  2026-07-20

  The reference study demonstrates that anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with superior anti-angiogenic effects compared to existing clinical agents. By targeting VEGFR2, PDGFRβ, and FGFR1, anlotinib disrupts key pathways driving endothelial cell migration and capillary formation, offering valuable mechanistic insights for cancer research.

• SLC25A1 Drives Cisplatin Resistance via H3K27ac-Senescence i

  2026-07-20

  Li et al. (2026) reveal that SLC25A1 upregulation confers cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) through H3K27 acetylation-mediated cellular senescence. These findings establish SLC25A1 as both a predictive biomarker and a therapeutic target for chemoresistant HNSCC, informing translational research and senescence assay design.

• Fucoidan Mitigates Irinotecan-Induced Steatohepatitis via Gu

  2026-07-19

  This study uncovers a mechanistic link between Irinotecan (CPT-11)-induced steatohepatitis and gut–liver axis disruption, highlighting the pathological role of intestinal barrier dysfunction and neutrophil extracellular traps (NETs) in hepatic injury. Fucoidan was demonstrated to restore intestinal integrity, suppress NETs formation, and attenuate liver inflammation, offering a targeted strategy for preventing chemotherapy-associated hepatotoxicity.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow

  2026-07-18

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) provides researchers with an affinity-purified, horseradish peroxidase-conjugated secondary antibody for reliable detection and signal amplification in immunoassays using rabbit primary antibodies. It is designed for workflows such as Western blot, ELISA, and immunohistochemistry where specificity for rabbit IgG (H+L) is required. This reagent is not suitable for diagnostic or clinical applications or when strict species or subclass discrimination is needed.

• ECL Chemiluminescent Substrate Detection Kit: Workflow & Adv

  2026-07-17

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) empowers researchers with ultra-sensitive, low-picogram protein detection and extended luminescence for western blot chemiluminescence detection. Discover stepwise protocols, troubleshooting strategies, and actionable insights inspired by recent neuroinflammation research.

• Carvedilol in β-Adrenergic Receptor Research: Applied Protoc

  2026-07-17

  Carvedilol stands out as a dual β- and α1-adrenergic receptor antagonist with unique antioxidant and vascular-modulating properties, making it indispensable for cardiovascular, vascular, and hematopoietic research. Explore actionable workflows, troubleshooting strategies, and a critical protocol update from recent hematopoietic regeneration studies to maximize your experimental outcomes.

• LY2109761: Mechanistic Insights and Translational Potential

  2026-07-16

  Explore the mechanistic impact of LY2109761, a potent TGF-β receptor type I and II dual inhibitor, on cancer and fibrosis models. This article delivers advanced assay insights and practical guidance for translational research applications.

• Deep Learning Reveals Cardiotoxicity Risks in iPSC-CM Drug S

  2026-07-16

  This study pioneers the integration of deep learning with high-content imaging to detect cardiotoxicity in human iPSC-derived cardiomyocytes. The approach enables scalable, early-stage prediction of drug-induced cardiac liabilities, offering significant implications for safer cancer chemotherapy development.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-07-15

  Harper et al. (2025) reveal that cell death following RNA polymerase II inhibition is not simply a passive consequence of mRNA and protein depletion, but is instead driven by active apoptotic signaling initiated by loss of the hypophosphorylated RNA Pol IIA form. This finding redefines how lethality is understood in transcription-targeting therapies and opens new questions about regulated cell death pathways.

• AMG 487 in CXCR3 Antagonism: From Mechanism to Translational

  2026-07-15

  Explore the in-depth mechanisms and translational significance of AMG 487, a potent CXCR3 antagonist, in modulating macrophage polarization and inflammatory responses. This article uniquely highlights the latest molecular insights and assay implications, providing a fresh perspective for advanced immunology research.

• Redefining Translational Apoptosis Detection: Mechanisms to

  2026-07-14

  This thought-leadership article empowers translational researchers with a mechanistic and strategic roadmap for apoptosis detection in tissue and cell models. Anchoring on the One-step TUNEL Cy5 Apoptosis Detection Kit, it blends recent immune-metabolic discoveries, workflow optimization, and competitive context to elevate the standards of programmed cell death analysis. The article uniquely bridges evidence from cutting-edge studies—including IRG1-itaconic acid–mediated immune regulation—and recent best practices, offering actionable guidance for advancing apoptosis assay design and interpretation.

• Next-Gen mRNA Tracking: Dual-Fluorescence, Dual Impact

  2026-07-14

  Explore how dual-labeled, chemically optimized mRNA tools are redefining translation efficiency assays and therapeutic development. Integrating mechanistic advances, recent electroporation breakthroughs, and APExBIO’s EZ Cap™ Cy5 EGFP mRNA (5-moUTP), this article offers translational researchers a detailed roadmap for enhancing mRNA delivery and immune evasion in cell-based studies.

• 5-HT3 Antiemetic Drugs Inhibit Renal OCT2 and MATE1 Transpor

  2026-07-13

  This study systematically evaluates how five clinically-used 5-HT3 antagonist antiemetic drugs inhibit renal organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1) in vitro. The findings highlight the potential for pharmacologically significant drug-drug interactions affecting cationic drug secretion, with direct implications for both preclinical modeling and translational pharmacology.

• Obacunone Reduces Neuroinflammation for SCI Recovery via TLR

  2026-07-13

  This study demonstrates that obacunone, a natural limonoid, significantly enhances functional recovery after spinal cord injury by suppressing neuroinflammation and apoptosis through inhibition of the TLR4/MyD88/p38 MAPK pathway. The findings provide mechanistic insight and preclinical evidence supporting obacunone’s potential as a therapeutic candidate for SCI.

• Caspase-3/7 Inhibitor I: Precision Apoptosis Control in Rese

  2026-07-12

  Caspase-3/7 Inhibitor I empowers researchers to dissect apoptosis pathways with nanomolar precision and reversible selectivity. Discover protocol enhancements, real-case troubleshooting, and advanced applications in infection and cancer models that elevate your cell death studies.

14806 records 1/988 page Next 12345 下5页 Last page